Correction: Brüning-Richardson et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models.

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
04 Aug 2022
Historique:
received: 07 06 2022
accepted: 27 06 2022
entrez: 12 8 2022
pubmed: 13 8 2022
medline: 13 8 2022
Statut: epublish

Résumé

The authors wish to make the following corrections to this paper [1][...].

Identifiants

DOI: 10.3390/cancers14153789 PMID: 35954505 PMC: PMC9367507
pubmed: 35954505
pii: cancers14153789
doi: 10.3390/cancers14153789
pmc: PMC9367507
pii:
doi:

Types de publication

Published Erratum

Langues

eng

Commentaires et corrections

Type : ErratumFor

Références

Cancers (Basel). 2021 Nov 25;13(23):
pubmed: 34885051

Auteurs

Anke Brüning-Richardson (A)

Leeds Institute of Medical Research at St James's, University of Leeds, Leeds LS9 7TF, UK.
ORCID: 0000-0002-9862-9805

Gary C Shaw (GC)

Leeds Institute of Medical Research at St James's, University of Leeds, Leeds LS9 7TF, UK.
ORCID: 0000-0001-9344-4433

Daniel Tams (D)

Leeds Institute of Medical Research at St James's, University of Leeds, Leeds LS9 7TF, UK.

Tim Brend (T)

Leeds Institute of Medical Research at St James's, University of Leeds, Leeds LS9 7TF, UK.
ORCID: 0000-0001-9703-7042

Hitesh Sanganee (H)

Discovery Sciences BioPharmaceuticals R&D, AstraZeneca, Cambridge CB2 8PA, UK.

Simon T Barry (ST)

Bioscience, Early Oncology, Oncology R&D, AstraZeneca, Cambridge CB2 8PA, UK.

Gregory Hamm (G)

Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB2 8PA, UK.
ORCID: 0000-0002-0769-9411

Richard J A Goodwin (RJA)

Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB2 8PA, UK.

John G Swales (JG)

Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB2 8PA, UK.

Henry King (H)

Leeds Institute of Medical Research at St James's, University of Leeds, Leeds LS9 7TF, UK.

Lynette Steele (L)

Leeds Institute of Medical Research at St James's, University of Leeds, Leeds LS9 7TF, UK.

Ruth Morton (R)

Leeds Institute of Medical Research at St James's, University of Leeds, Leeds LS9 7TF, UK.

Anastasia Widyadari (A)

Leeds Institute of Medical Research at St James's, University of Leeds, Leeds LS9 7TF, UK.

Thomas A Ward (TA)

Leeds Institute of Medical Research at St James's, University of Leeds, Leeds LS9 7TF, UK.
ORCID: 0000-0003-0937-4554

Filomena Esteves (F)

Leeds Institute of Medical Research at St James's, University of Leeds, Leeds LS9 7TF, UK.

Marjorie Boissinot (M)

Leeds Institute of Medical Research at St James's, University of Leeds, Leeds LS9 7TF, UK.
ORCID: 0000-0002-5241-2520

Georgia Mavria (G)

Leeds Institute of Medical Research at St James's, University of Leeds, Leeds LS9 7TF, UK.

Alastair Droop (A)

Leeds MRC Medical Bioinformatics Centre, University of Leeds, Leeds LS9 7TF, UK.
ORCID: 0000-0001-7695-7480

Sean E Lawler (SE)

Pathology & Laboratory Medicine, Brown University Cancer Center, Brown University, Providence, RI 02903, USA.

Susan C Short (SC)

Leeds Institute of Medical Research at St James's, University of Leeds, Leeds LS9 7TF, UK.

Classifications MeSH